| Axon guidance |
24.08
|
cell adhesion |
22.90
|
| Wnt signaling pathway |
23.66 |
blood coagulation |
14.72
|
| Pathways in cancer |
23.50
|
angiogenesis |
13.83
|
| p53 signaling pathway |
21.19
|
canonical Wnt receptor signaling pathway |
8.99
|
| Ubiquitin mediated proteolysis |
20.44
|
platelet activation |
7.46
|
| Transcriptional misregulation in cancer |
20.10
|
wound healing |
7.40
|
| TGF-beta signaling pathway |
20.08 |
positive regulation of angiogenesis |
5.74
|
| Endocytosis |
19.75
|
Wnt receptor signaling pathway, calcium modulating pathway |
5.57
|
| Melanogenesis |
18.83
|
vascular endothelial growth factor receptor signaling pathway |
5.44
|
| Gap junction |
17.13 |
negative regulation of canonical Wnt receptor signaling pathway |
5.03
|
| GnRH signaling pathway |
16.65
|
Wnt receptor signaling pathway |
4.55
|
| Prostate cancer |
15.97
|
Notch signaling pathway |
4.51
|
| MAPK signaling pathway |
15.18
|
cell-matrix adhesion |
4.35
|
| HTLV-I infection |
15.18
|
negative regulation of cell adhesion |
3.95
|
| Salivary secretion |
13.52
|
transforming growth factor beta receptor signaling pathway |
3.95
|
| Calcium signaling pathway |
13.35
|
regulation of cell adhesion |
3.65
|
| ABC transporters |
13.09
|
positive regulation of endothelial cell migration |
3.60
|
| Melanoma |
12.52
|
positive regulation of vasoconstriction |
3.60
|
| Regulation of actin cytoskeleton |
12.17
|
positive regulation of endothelial cell proliferation |
3.37
|
| ErbB signaling pathway |
12.17
|
blood vessel development |
3.17
|
